Monographie - Docetaxel

Viimeisin päivitys :
03/05/2024

Docetaxel

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adenex	Kolumbia
Asodocel	Argentiina
Axogen	Chile
Bagotaxel	Chile
Bendadocel	Saksa
Brecasta	Chile
Celtere	Marokko
Daxotel	Chile, Egypti, Kolumbia, Malesia
Doce NC	Saksa
Docefrez	Intia, Yhdysvallat
Docekebir	Argentiina
Docetax	Iran, Venezuela
Docetaxin	Saksa
Docewin	Marokko
Dolectran	Argentiina
Donataxel	Argentiina, Ecuador, Marokko
Doxel	Turkki, Venezuela
Doxetal	Argentiina
Doxitax	Turkki
Oncodocel	Kolumbia, Marokko
Onkotaxel	Itävalta, Kolumbia
Ribodocel	Saksa
Santax	Turkki
Tadocel	Turkki
Taxceus	Iso-Britannia
Taxotan	Saksa
Taxotere	Argentiina, Australia, Belgia, Chile, Ecuador, Egypti, Espanja, Hollanti, Iran, Islanti, Iso-Britannia, Italia, Itävalta, Japani, Kanada, Kolumbia, Kreikka, Kroatia, Luxemburg, Malesia, Marokko, Meksiko, New Zealand, Norja, Portugali, Puola, Ranska, Romania, Ruotsi, Saksa, Saudi-Arabia, Suomi, Sveitsi, Tanska, Thaimaa, Tunisia, Turkki, Unkari, Venezuela, Yhdistyneet arabiemiirikunnat, Yhdysvallat
Texot	Argentiina
Tolnexa	Romania
Zenotere	Intia, Marokko

Viitteet : Docetaxel

	Tyyppi	Julkaisu
140	Lehti	Pearson SD, Trissel LA. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Am J Hosp Pharm 1993 ; 50: 1405-1409.
250	Lehti	Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. Am J Health-Syst Pharm 1997 ; 54: 566-569.
251	Lehti	Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423	Lehti	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1660	Lehti	Thiesen J, Krämer I. Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers. Pharm World Sci 1999 ; 21: 137-141.
1662	Lehti	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1754	Lehti	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1940	Lehti	Xu QA, Trissel LA. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953	Lehti	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Lehti	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175	Lehti	Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J. Peut-on conditionner les solutions de docétaxel dans des poches en PVC ? J Pharm Clin 2006 ; 25, 3: 147-152.
2210	Lehti	Walker S.E, Charbonneau F, Law S. Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags. Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262	Lehti	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341	Ilmoitus	Bourlon S, Sautou-Miranda V, Dalle M. Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions Poster ESCP Stockholm May 2005
3130	Laboratorio	Docétaxel (Taxotere®) – Résumé des caractéristiques du produits Sanofi Avantis France 2009
3163	Lehti	Acott SR, Hart M. Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage. EJHP 2010 ; 16, 5: 26-28.
3195	Lehti	MacLeod S, Sewell G. Physical and chemical stability of docetaxel infusions. EJHP 2011 ; 17, 2: 39-43.
3215	Lehti	Hart MC, Ahmed W. Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution. EJOP 2011 ; 5,1: 24-27.
3277	Lehti	Yang Z, Cameron S, Paul H. Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration. Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804	Lehti	Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A. Physicochemical stability of cabazitaxel and docetaxel solutions. EJHP 2014 ;22:150-155.
3937	Lehti	Park K.H, Chung D.J. Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Biomat Res 2015 ; 19, 2

Mentions Légales